CVS Health Corporation’s Stock Price Soars to $48.01, Marking a Robust 4.35% Uptick

CVS Health Corporation (CVS)

48.01 USD +2.00 (+4.35%) Volume: 16.38M

CVS Health Corporation’s stock price surges to $48.01, marking a noteworthy increase of +4.35% this trading session with a robust trading volume of 16.38M shares. With a year-to-date percentage change of +6.95%, CVS’s stock continues its upward trend, showcasing strong performance in the market.

Latest developments on CVS Health Corporation

Today, CVS Health Corp stock experienced modest gains as Moon Capital Management liquidated their position with a modest gain. Market whales have been making recent bets on CVS options, contributing to the stock’s movement. Despite a slight decrease of 0.09%, CVS Health Corp stock outperformed competitors on a strong trading day. Douglas Lane & Associates LLC also lowered their position in CVS Health Co. However, CVS successfully converted commercial pharmacy contracts to a “cost plus” model, which may have contributed to its attractiveness with a safe yield of 5.8%. After a significant 40% fall in 2024, investors are now looking to see if CVS Health stock can turn things around this year.

CVS Health Corporation on Smartkarma

Analysts on Smartkarma have differing views on Cvs Health Corp. According to a report from Value Investors Club, the author suggests a potential 30%+ downside for CVS due to declining performance in its Pharmacy & Consumer Wellness operations. The author compares CVS’s situation to using bad grapes to make wine, indicating a terminal segment. They recommend pair trades such as going long on CI and short on CVS. On the other hand, Baptista Research presents a bullish perspective on CVS Health Corporation, highlighting its strategic leverage in Pharmacy Benefit Management (PBM) and Insurance Operations. Despite challenges in the Health Care Benefits segment, CVS saw revenues exceeding $91 billion and an adjusted EPS of $1.83 in the second quarter of 2024.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Cvs Health Corp seems to have a positive long-term outlook. With high scores in both Value and Dividend, investors may see potential for good returns and steady income. However, the company scores lower in Growth, Resilience, and Momentum, indicating some challenges in those areas that may need to be addressed for sustained success.

Cvs Health Corp is an integrated pharmacy health care provider with a strong focus on pharmacy benefit management services and retail pharmacy operations. Despite facing some challenges in growth and momentum, the company’s high scores in value and dividend suggest stability and potential for profitability in the long term. Investors may want to keep an eye on how the company addresses its growth and resilience factors to ensure continued success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma